Q2 2026 CTS Corp Earnings Call Transcript

Jul 28, 2026 / 02:00 PM GMT
Release Date Price: €52.5 (+0.96%)

Key Points

Positve
  • CTS Corp (CTS) reported a 7% increase in second-quarter sales compared to the same period in 2025, with a 4% sequential growth from the first quarter of 2026.
  • The company achieved a record adjusted gross margin of 41.5%, up 270 basis points year over year.
  • CTS Corp (CTS) secured several new business awards totaling $163 million, including a significant win with a North American OEM.
  • The medical end market saw a 45% year-over-year revenue increase, driven by strong demand for advanced diagnostics and therapeutic treatments.
  • The industrial market continued its strong momentum with a 16% year-over-year sales increase, supported by broad-based customer demand and healthy bookings.
Negative
  • Transportation sales were down 2% year over year and sequentially, reflecting challenges in the automotive sector.
  • Space and defense sales decreased by 15% year over year, although there was a 4% sequential increase.
  • The company faces ongoing geopolitical and tariff-related uncertainties, which could impact future performance.
  • CTS Corp (CTS) anticipates flat to modestly down vehicle production volumes due to geopolitical and consumer demand uncertainties.
  • The commercial vehicle market's growth is expected to be modest, with potential dampening effects on gross margins as volumes return.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CTS.N - CTS Corp
Q2 2026 CTS Corp Earnings Call
Jul 28, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
I would like to remind our listeners the call contains forward-looking statements.

These statements are subject to a number of recenties that could cause actual results to differ materially from those expressed in the forward-looking statements.

Additional information regarding these risks and issued today, and more information can be found in the company's SEC filings.

To the extent that today's discussion refers to any non-GAAP measures under regulation, the required explanations and reconciliations are available with today's earnings press release and the supple presentation which can be found in our investors section of the CTS website.

I will now turn the discussion back over to Pratik.

Thank you, we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot